Biohaven Leaps After Posting $93M Sales for Migraine Drug

Biohaven Leaps After Posting $93M Sales for Migraine Drug

Submitted by admin on July 7, 2021 - 12:00pm
Source: 
TheStreet.com
News Tags: 
Biohaven
migraines
Nurtec
Headline: 
Biohaven Leaps After Posting $93M Sales for Migraine Drug
snippet: 

Biohaven's Nurtec was approved for migraine treatment in February 2020 and for prevention this past May. Q2 sales: $93 million.

Do Not Allow Advertisers to Use My Personal information